Daiichi Sankyo, a Japan-based company, will be selling its entire or a part of its 8.9 percent stake (worth Rs 22,500 crore) in the Indian drug company Sun Pharma. “After the sale, Daiichi Sankyo will not be a major shareholder of Sun Pharma. However, the existing business partnership with Sun Pharma will remain unchanged,” Daiichi Sankyo said.